Check out our deepdive here
But while generic versions could have been introduced in Canada earlier this year, so far, they havent appeared
Meaning Medicare Part D coverage of GLP-1RAs to treat obesity would lead to a substantial net increase in future Medicare spending, and policymakers should leverage a comprehensive range of strategies, including further price reductions resulting from Medicares drug price negotiation under the Inflation Reduction Act, lower cost strategies to prevent weight regain, and reductions in spending on unnecessary care
How long you continue depends on your results, lifestyle changes, how well you tolerate the medication, and overall health goals
Additionally, it may regulate oxidative stress and platelet activation in surgical process [36]
We want you to lose fat, not health